20. November 2009 01:12
Accumetrics, Inc., developer of the VerifyNow System, the first point-of-care method for measuring platelet reactivity, announces that its market-leading VerifyNow P2Y12 Test was one of multiple methods evaluated in the POPular study, which was presented during a Late Breaking Clinical Trials session at the American Heart Association's annual Scientific Sessions.
[More]
19. November 2009 03:26
Patients should avoid using the stomach acid reducer Prilosec/Prilosec OTC (omeprazole) with the anti-clotting drug Plavix (clopidogrel), the U.S. Food and Drug Administration warned on Nov. 17.
[More]
19. November 2009 02:50
AstraZeneca today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ticagrelor, an investigational oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndrome (ACS).
[More]
7. November 2009 02:28
With his proposed health care reform plan, President Barack Obama has set his sights on cutting name-brand prescription drug costs by 50 percent for Medicare patients who fall into the "Part D" coverage gap, universally known as the "donut hole." Plan advocates rave about the potential cost-cutting and feel it's a promising start to health care reform.
[More]
30. October 2009 08:59
In the third quarter of 2009, sanofi-aventis generated net sales of euro 7,400 million, up 8.0% on a reported basis. Exchange rate movements had a favorable effect of 2.0 percentage points, with the appreciation of the U.S. dollar (and to a lesser extent the yen) against the euro more than offsetting the unfavorable effects of some other currencies.
[More]
abcc0755-d96f-4ed2-bc9b-3df77f99e26c|0|.0
Posted in: Business / Finance
Tags: Ambien, Angioplasty, Antibody, Atrial Fibrillation, Biotechnology, Breast Cancer, Cancer, Cardiology, Cervical Cancer, Chemotherapy, Clopidogrel, Conjunctivitis, Cyclosporine, Dermatology, Diabetes, Diphtheria, Estrogen, Gardasil, H1N1, H5N1, Haemophilus influenzae Type B, Heparin, Hepatitis B, Influenza, Insomnia, Insulin, Lantus, Leukemia, Lymphoma, Meningitis, Monoclonal Antibody, Multaq, Multiple Sclerosis, Oncology, Ophthalmology, Pandemic, Plavix, Pneumonia, Polio, Progesterone, Sleep, Taxotere, Tetanus, Type 2 Diabetes, Vaccine
22. October 2009 08:08
Bristol-Myers Squibb Company today reported strong sales and earnings growth for the third quarter 2009.
[More]
fc89edfd-87d8-443c-bf50-560729ad8450|0|.0
Posted in: Business / Finance
Tags: Abilify, Angioplasty, Antibody, Apixaban, Arthritis, Cancer, Capecitabine, Cardiology, Chemotherapy, Colorectal Cancer, Diabetes, Diabetes Mellitus, Hemostasis, Hepatitis B, Immunology, Medicaid, Medicare, Metformin, Nutrition, Oncology, Onglyza, Oxaliplatin, Plavix, Prescription Drug, Rheumatoid Arthritis, Saxagliptin, Sprycel, Stroke, Thrombosis, Type 2 Diabetes
21. October 2009 05:38
A higher percentage of companies are using Comparative Effectiveness Research to help with pricing and reimbursement decisions, according to new research from Cutting Edge Information.
[More]
14. October 2009 08:15
Research and Markets (http://www.researchandmarkets.com/research/3e7026/partnering_in_the) has announced the addition of the "Partnering in the Global Generics Industry 2009: A Guide to Companies" report to their offering.
[More]
8. October 2009 05:15
DNA testing for gene variants that can increase the risk of major coronary events in certain patients taking the anti-clotting drug Plavix® (clopidogrel bisulfate) is now being performed by Quest Diagnostics for Scripps Health patients electing to undergo coronary stent procedures.
[More]
4b5c4d04-ce3b-41c7-885f-b56b5d13baa4|0|.0
Posted in: Medical Condition News
Tags: Cardiovascular Disease, Clopidogrel, DNA, Education, Effient, Genetics, Hospital, Plavix, Prasugrel, Stent, Stroke
8. October 2009 02:37
IMS Health reported today that the value of the global pharmaceutical market in 2010 is expected to grow 4 - 6 percent on a constant-dollar basis, exceeding $825 billion, driven by stronger near-term growth in the U.S. market.
[More]
3. October 2009 09:02
The Harvard Clinical Research Institute (HCRI) announced today that the first patients have been enrolled in the DAPT Study, marking the official initiation of the four-year clinical trial to investigate the duration of dual antiplatelet therapy (DAPT, the combination of aspirin and a thienopyridine/antiplatelet medication to reduce the risk of blood clots) following drug-eluting stent implantations.
[More]
30. September 2009 06:18
Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
[More]
21. September 2009 07:24
This analysis examines the historical and forecast performance for BMS in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
[More]
3eecd1a7-e9f1-4720-917d-d5be8794ec2d|0|.0
Posted in: Business / Finance
Tags: Abilify, Antipsychotic, Apixaban, Hepatitis B, Immunology, Nervous System, Oncology, Onglyza, Pfizer, Plavix, Sprycel, Truvada, Zyprexa
9. September 2009 05:03
Reportlinker.com announces that a new market research report is available in its catalogue. Prescription Drugs
[More]
c41f7647-a414-45a8-8e20-6e38c881d7a0|0|.0
Posted in: Pharmaceutical News
Tags: Actos, Alzheimer's Disease, Angiotensin, Antibody, Antidepressant, Antipsychotic, Artemisinin, Arthritis, Asthma, Atenolol, Biotechnology, Calcium, Cancer, Cell, Cholesterol, Cystic Fibrosis, Depakote, Dermatology, Diabetes, Dopamine, Dysport, Erythropoietin, Evolution, Exelon, Fibrosis, Generic Drug, H5N1, Hospital, Huntington's Disease, Insomnia, Lantus, Multiple Sclerosis, New Drug Application, Nexium, Oncology, Osteoporosis, Painkiller, Pfizer, Plavix, Rheumatoid Arthritis, Rhinitis, Schizophrenia, Seroquel, Serotonin, Statin, Stem Cell, Tarceva, Tetrabenazine, Tuberculosis, Type 2 Diabetes, Vaccine, Voltaren, Vytorin, Wellbutrin, Zocor, Zyprexa, Zyrtec
2. September 2009 09:31
Accumetrics, Inc. has announced the signing of a new exclusive distribution agreement for its VerifyNow(R) System in Spain, Portugal and Chile with Grifols S.A.. This distribution agreement will continue to expand Accumetrics' reach in both scope and geography, and add to the growing numbers of countries where physicians have access to the VerifyNow System.
[More] 
Subscribe